by jlohrconsulting | Sep 3, 2025 | Uncategorized
J Clin Psychopharmacol. 2025 Sep 3. doi: 10.1097/JCP.0000000000002061. Online ahead of print. ABSTRACT PURPOSE/BACKGROUND: Multiple meta-analyses have suggested that pharmacogenomic (PGx) testing may be a valuable tool to improve clinical outcomes for patients with...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
PLoS One. 2025 Sep 3;20(9):e0328785. doi: 10.1371/journal.pone.0328785. eCollection 2025. ABSTRACT BACKGROUND: By investigating the depression, anxiety and stress status of secondary school students, we further analysed the influencing factors of the changes in...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
PLoS One. 2025 Sep 3;20(9):e0320821. doi: 10.1371/journal.pone.0320821. eCollection 2025. ABSTRACT BACKGROUND: Low participant recruitment and retention rates are a significant barrier to successful Randomised Controlled Trials (RCTs). A Study Within A Trial (SWAT) is...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Aging Dis. 2025 Aug 28. doi: 10.14336/AD.2025.0781. Online ahead of print. ABSTRACT Major depressive disorder (MDD) is a prevalent mental illness characterized by significant morbidity and mortality. Cognitive impairment is a common feature of MDD, closely related to...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
J Med Internet Res. 2025 Sep 3;27:e81689. doi: 10.2196/81689. ABSTRACT [This corrects the article DOI: 10.2196/55583.]. PMID:40902152 | DOI:10.2196/81689
by jlohrconsulting | Sep 3, 2025 | Uncategorized
JMIR Res Protoc. 2025 Sep 3;14:e73387. doi: 10.2196/73387. ABSTRACT BACKGROUND: Nearly all individuals with Alzheimer disease and related dementias (ADRD) experience behavioral and psychological symptoms of dementia (BPSD), which include symptoms such as agitation,...
Recent Comments